203 related articles for article (PubMed ID: 9928552)
1. Ductal carcinoma in situ of the breast: histological classification and genetic alterations.
van de Vijver MJ
Recent Results Cancer Res; 1998; 152():123-34. PubMed ID: 9928552
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoma in situ of the breast].
Laenkholm AV; Hoffmann J; Rank FE
Ugeskr Laeger; 2007 Sep; 169(37):3087-90. PubMed ID: 17877955
[TBL] [Abstract][Full Text] [Related]
4. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
Rane SU; Mirza H; Grigoriadis A; Pinder SE
Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
[TBL] [Abstract][Full Text] [Related]
5. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
[TBL] [Abstract][Full Text] [Related]
6. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
Buerger H; Otterbach F; Simon R; Poremba C; Diallo R; Decker T; Riethdorf L; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097
[TBL] [Abstract][Full Text] [Related]
8. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer.
Elias EV; de Castro NP; Pineda PH; Abuázar CS; Bueno de Toledo Osorio CA; Pinilla MG; da Silva SD; Camargo AA; Silva WA; E Ferreira EN; Brentani HP; Carraro DM
Oncotarget; 2016 Nov; 7(46):75672-75684. PubMed ID: 27708222
[TBL] [Abstract][Full Text] [Related]
9. [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis].
Böcker W; Decker T; Ruhnke M; Schneider W
Pathologe; 1997 Jan; 18(1):3-18. PubMed ID: 9157402
[TBL] [Abstract][Full Text] [Related]
10. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
[TBL] [Abstract][Full Text] [Related]
11. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
[TBL] [Abstract][Full Text] [Related]
12. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.
Simpson JF; O'Malley F; Dupont WD; Page DL
Cancer; 1994 May; 73(9):2352-8. PubMed ID: 7513249
[TBL] [Abstract][Full Text] [Related]
14. A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.
Moriya T; Kasami M; Akiyama F; Ichihara S; Kurosumi M; Tsuda H; Umemura S; Akashi-Tanaka S; Imamura H; Iwase H; Shin E; Harada Y; Mitsuyama S; Ohuchi N
Breast Cancer; 2000; 7(4):321-5. PubMed ID: 11114858
[TBL] [Abstract][Full Text] [Related]
15. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
Goldstein NS; O'Malley BA
Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
17. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).
Gupta SK; Douglas-Jones AG; Fenn N; Morgan JM; Mansel RE
Cancer; 1997 Nov; 80(9):1740-5. PubMed ID: 9351542
[TBL] [Abstract][Full Text] [Related]
18. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
19. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
[TBL] [Abstract][Full Text] [Related]
20. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
